The COVID-19 pandemic had a negative impact on patients with epilepsy, exhibited by increased rates of depression and poorer seizure control, according to a study. The medium-term study is a follow-up to a short-term, cross-sectional, survey-based study. The rate of depression was much higher than it was in the short-term analysis. In both the medium- and short-term surveys, patients reported high rates of anxiety and insomnia.

Read more.